ACA
ZBH icon

Aptus Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Aptus Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$550K Buy
6,384
+267
+4% +$23.4K ﹤0.01% 767
2026
Q1 		$553K Sell
6,117
-216
-3% -$19.8K ﹤0.01% 696
2025
Q4 		$569K Buy
6,333
+539
+9% +$51.1K ﹤0.01% 699
2025
Q3 		$571K Buy
+5,794
New +$574K ﹤0.01% 672

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aptus Capital Advisors's ZBH Position: Q2 2026 in Review

Aptus Capital Advisors increased its Zimmer Biomet (ZBH) stake by 4.4% in Q2 2026, buying an estimated $23.4K and bringing the position to 6,384 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Aptus Capital Advisors first reported a position in ZBH in Q3 2025 and has held it in 4 quarters since. The position peaked at $571K in Q3 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Aptus Capital Advisors held 6,384 shares of Zimmer Biomet worth $550K as of Q2 2026.
  • Aptus Capital Advisors bought 267 Zimmer Biomet shares in Q2 2026, an estimated $23.4K.
  • Zimmer Biomet made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #767 holding.
  • Aptus Capital Advisors first reported a position in Zimmer Biomet in Q3 2025 and has held it in 4 quarters since.
  • Aptus Capital Advisors's Zimmer Biomet position peaked at $571K in Q3 2025.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.